Arrowhead Pharmaceuticals launched 'We'll Get There Soon' campaign on FCS Awareness Day to raise awareness about Familial Chylomicronemia Syndrome, a rare condition causing high triglyceride levels. The campaign aims to provide hope to those affected by this severe disease.